Xuejun Xiao | Bioinformatics | Best Researcher Award

Published on by Technology Scientists

Best Researcher Award

                    Xuejun Xiao
Affiliation Xinjiang Medical University
Country China
Scopus ID 56640335200
Documents 8
Citations 132
h-index 4
Subject Area Bioinformatics
Event Technology Scientists Awards

Xuejun Xiao, Xinjiang Medical University

Xuejun Xiao is affiliated with Xinjiang Medical University, China, and has contributed to bioinformatics and biomedical research through scholarly publications indexed in Scopus. The researcher has authored eight indexed publications, received more than one hundred citations, and demonstrated continued academic engagement in cancer biology, immunology, and nanomedicine research. [1]

Abstract

Xuejun Xiao has contributed to interdisciplinary bioinformatics research with emphasis on cancer biology, immune regulation, molecular therapeutics, and nanoparticle-assisted drug delivery. Published studies investigate immune checkpoint modulation, mechanisms of chemotherapy resistance, and advanced biomedical technologies supporting precision medicine. The available scholarly record demonstrates sustained scientific productivity and measurable citation impact within indexed literature. These achievements indicate meaningful participation in translational biomedical research while supporting future innovation in computational biology, oncology, and therapeutic development through collaborative scientific investigation and evidence-based methodologies. [1] [2] [3]

Keywords

Bioinformatics, Cancer Research, Nanoparticles, Drug Delivery, Gastric Cancer, LUAD, Immunotherapy, Siglec-15, Precision Medicine, Computational Biology.

Introduction

Bioinformatics integrates computational methods with biomedical sciences to improve disease understanding and therapeutic discovery. Xuejun Xiao’s scholarly activities align with this interdisciplinary approach by examining molecular mechanisms associated with cancer progression, immune regulation, and targeted treatment strategies through evidence-based experimental investigations. [1]

Research Profile

The research profile demonstrates experience in oncology, molecular biology, and translational medicine. Indexed publications, citation performance, and collaborative scientific outputs illustrate continued participation in biomedical research focused on identifying clinically relevant biomarkers and innovative therapeutic approaches supporting improved patient outcomes. [2]

Research Contributions

Research contributions include investigations into nanoparticle-mediated antibody delivery, immune checkpoint inhibition, macrophage polarization, and mechanisms responsible for chemotherapy resistance. These studies provide valuable scientific knowledge supporting precision oncology and future therapeutic development through multidisciplinary biomedical research collaborations. [1] [3]

Publications

The Scopus record reports eight indexed publications covering bioinformatics, immunology, cancer biology, and targeted therapeutics. These publications have received academic recognition through citations, reflecting their relevance within contemporary biomedical research and contribution to ongoing scientific discussions in related disciplines. [1]

Research Impact

Citation metrics indicate measurable academic influence, with published research supporting continued investigations into molecular oncology and immunotherapy. The combination of citation performance, interdisciplinary collaborations, and translational relevance highlights the significance of the research within biomedical and bioinformatics communities. [2]

Award Suitability

Based on available scholarly indicators, publication quality, citation record, and sustained contributions to bioinformatics and biomedical sciences, Xuejun Xiao demonstrates qualifications consistent with recognition under the Best Researcher Award for advancing scientific knowledge through impactful and collaborative academic research. [1]

Conclusion

Xuejun Xiao’s academic portfolio reflects meaningful contributions to bioinformatics and cancer research through peer-reviewed publications addressing clinically important biomedical challenges. Continued research activity and scholarly collaboration are expected to further support innovation, translational medicine, and evidence-based healthcare advancement. [1]

External Links

References

  1. Xiao, X., et al. (2026). Application of nanoparticles in antibody drug delivery. Frontiers in Bioengineering and Biotechnology.
    https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2026.1759915/full
  2. Xiao, X., et al. (2022). A novel immune checkpoint siglec-15 antibody inhibits LUAD by modulating macrophage polarization in the tumor microenvironment. Cancer Letters.
    https://www.sciencedirect.com/science/article/abs/pii/S1043661822002146
  3. Xiao, X., et al. (2020). PLOD2 increases resistance of gastric cancer cells to 5-fluorouracil by upregulating BCRP and inhibiting apoptosis. Cell Biology International.
    https://pubmed.ncbi.nlm.nih.gov/32284742/
  4. Elsevier. (n.d.). Scopus author details: Xuejun Xiao, Author ID 56640335200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56640335200

Assist. Prof. Dr. Marwa Balaha | Computational Biology | Research Excellence Award

Published on by Technology Scientists

Assist. Prof. Dr. Marwa Balaha | Computational Biology | Research Excellence Award

D’Annunzio University of Chieti–Pescara | Italy

Assist. Prof. Dr. Marwa Balaha, affiliated with the Faculty of Pharmacy in Kafr El-Sheikh, Egypt, is an emerging researcher in the fields of medicinal chemistry, pharmacology, and drug discovery. Her research primarily focuses on the design, synthesis, and biological evaluation of novel therapeutic compounds, particularly targeting metabolic disorders and wound healing applications. With a portfolio of 26 indexed publications, 281 citations and h-index: 11, she demonstrates a consistent contribution to bioactive compound development and translational pharmaceutical research. Her recent work on thiazolidinedione-based dual inhibitors and innovative chromenyl–pyrazolyl derivatives highlights her expertise in multi-target drug design and in vivo validation. Dr. Balaha has established a broad collaborative network, reflected in her extensive co-authorship, facilitating interdisciplinary research across chemistry and biomedical sciences. Her work contributes to addressing global health challenges such as diabetes and tissue regeneration, underscoring its scientific relevance and potential societal impact.

Citation Metrics (Scopus)

281
200
100
10
0

Citations

281

Documents

26

h-index

11

Citations

Documents

h-index


View Scopus Profile
 View ORCID Profile
 View Google Scholar Profile
 View ResearchGate Profile

Top 5 Featured Publications

Vasuk Gautam | Bioinformatics | Best Researcher Award

Published on by Technology Scientists

Dr. Vasuk Gautam | Bioinformatics | Best Researcher Award

Sr.Scientist | Norton Research Institute | United States

Dr. Vasuk Gautam is an emerging researcher whose work spans metabolomics, biomarker discovery, and computational methods for enhancing analytical confidence in high-throughput biological studies. With a record of 24 peer-reviewed publications, 13 h-index and over 3,102 citations, Gautam has established a strong early-career footprint marked by methodological innovation and extensive interdisciplinary collaboration. His contributions focus particularly on developing frameworks for improving metabolite identification accuracy—an essential challenge in metabolomics that directly influences the reliability of biomedical and environmental research. Notably, his recent work introducing the concept of “Identification Probability” provides a transferable, automated metric for evaluating identification confidence, positioning it as a potentially transformative tool for large-scale metabolomic pipelines. In parallel, Gautam has contributed significantly to the development of MarkerDB 2.0, a comprehensive biomarker database that integrates molecular, clinical, and contextual information to support precision medicine, translational research, and global health initiatives. His scholarship reflects a blend of computational rigor, domain expertise, and a commitment to open-access scientific resources. Gautam’s collaborations include partnerships with over 180 co-authors, underscoring his active engagement with diverse research groups and his ability to contribute meaningfully to multi-institutional projects. This collaborative network spans biochemistry, bioinformatics, systems biology, and clinical sciences, highlighting the broad applicability and relevance of his expertise. Through both his methodological contributions and his involvement in global data-resource efforts, Gautam’s work supports reproducibility, accessibility, and evidence-based discovery in molecular life sciences. His growing citation impact and participation in influential open-access initiatives demonstrate both scientific merit and societal relevance, particularly in areas related to disease diagnostics, personalized healthcare, and data-driven research infrastructures.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

1. Wishart, D. S., Guo, A. C., Oler, E., Wang, F., Anjum, A., Peters, H., Dizon, R., … (2022). HMDB 5.0: The human metabolome database for 2022. Nucleic Acids Research, 50(D1), D622–D631.

Cited by: 2116

2. Knox, C., Wilson, M., Klinger, C. M., Franklin, M., Oler, E., Wilson, A., Pon, A., Cox, J., … (2024). DrugBank 6.0: The DrugBank knowledgebase for 2024. Nucleic Acids Research, 52(D1), D1265–D1275.

Cited by: 1112

3. Wishart, D. S., Han, S., Saha, S., Oler, E., Peters, H., Grant, J. R., Stothard, P., … (2023). PHASTEST: Faster than PHASTER, better than PHAST. Nucleic Acids Research, 51(W1), W443–W450.

Cited by: 394

4. Wishart, D. S., Tian, S., Allen, D., Oler, E., Peters, H., Lui, V. W., Gautam, V., … (2022). BioTransformer 3.0: A web server for accurately predicting metabolic transformation products. Nucleic Acids Research, 50(W1), W115–W123.

Cited by: 160

5. Wang, F., Allen, D., Tian, S., Oler, E., Gautam, V., Greiner, R., Metz, T. O., … (2022). CFM-ID 4.0: A web server for accurate MS-based metabolite identification. Nucleic Acids Research, 50(W1), W165–W174.

Cited by: 115

Dr. Vasuk Gautam’s work advances the reliability and scalability of metabolomic and biomarker research, enabling more accurate diagnostics and deeper biological insight. By developing robust identification metrics and contributing to global data resources, he helps accelerate scientific discovery, support precision medicine, and enhance evidence-based decision-making across research, healthcare, and industry.

Béchir Béjaoui | Bioinformatics | Editorial Board Member

Published on by Technology Scientists

Prof. Béchir Béjaoui | Bioinformatics | Editorial Board Member

Researcher | National Institute of Marine Sciences and Technologies | Tunisia

Prof. Béchir Béjaoui is a distinguished marine and environmental scientist affiliated with the National Institute of Marine Sciences and Technologies (INSTM) in Carthage, Tunisia. His research primarily focuses on coastal and marine ecosystem dynamics, climate change impacts, and the application of advanced modeling and machine learning techniques to assess and manage aquatic environments. Over his career, Dr. Béjaoui has authored 34 scientific publications, collectively cited more than 1,130 times across 954 documents, reflecting his strong academic influence and the global relevance of his research. His work integrates remote sensing, numerical modeling, and ecological indicators to evaluate trophic states, water quality, and biodiversity in sensitive environments, such as the Ichkeul Lake Ramsar sanctuary—a UNESCO biosphere reserve and a critical wetland ecosystem in North Africa. Dr. Béjaoui’s studies, including the development of innovative models such as the TRIX-XGBoost Trophic Model and data-driven approaches for forecasting environmental change, provide valuable insights into sustainable wetland management under anthropogenic and climatic pressures. With over 180 international collaborators, his research reflects a strong commitment to multidisciplinary and cross-institutional cooperation, enhancing the global understanding of marine system resilience. His contributions extend beyond academia to inform environmental policy, conservation planning, and adaptive management strategies, bridging the gap between scientific research and socio-environmental decision-making. Through his sustained scholarly output and leadership in marine ecosystem modeling, Dr. Béjaoui continues to play a pivotal role in advancing data-driven sustainability solutions in the Mediterranean and beyond.

Profile: Scopus

Featured Publications

1. Béjaoui, B., … (2025). TRIX-XGBoost Trophic Model for assessing the trophic status of Ichkeul Lake, a Ramsar sanctuary in Northern Tunisia. Marine Pollution Bulletin.

2. Béjaoui, B., … (2025). Remote sensing and numerical modeling to assess the drought in Ichkeul Lake, a RAMSAR wetland and UNESCO biosphere reserve, under climate change. Regional Studies in Marine Science.

3. Béjaoui, B., … (2025, Conference Paper). Machine learning techniques for forecasting the effect of climate change and anthropogenic pressures on coastal wetlands (Ichkeul Lake, Ramsar site).

Prof. Béjaoui’s work drives innovation in environmental modeling, offering scientifically grounded tools to safeguard fragile aquatic ecosystems against climate and human-induced stressors. His research vision promotes sustainable management of marine and wetland resources, contributing to global efforts toward ecological resilience, climate adaptation, and sustainable development.